These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 10955804

  • 1. Enhanced expression of N-myc messenger RNA in neuroblastomas found by mass screening.
    Matsunaga T, Shirasawa H, Hishiki T, Yoshida H, Kouchi K, Ohtsuka Y, Kawamura K, Etoh T, Ohnuma N.
    Clin Cancer Res; 2000 Aug; 6(8):3199-204. PubMed ID: 10955804
    [Abstract] [Full Text] [Related]

  • 2. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
    Nakagawara A, Kadomatsu K, Sato S, Kohno K, Takano H, Akazawa K, Nose Y, Kuwano M.
    Cancer Res; 1990 May 15; 50(10):3043-7. PubMed ID: 2185879
    [Abstract] [Full Text] [Related]

  • 3. Expression of alternatively spliced src messenger RNAs related to neuronal differentiation in human neuroblastomas.
    Matsunaga T, Shirasawa H, Tanabe M, Ohnuma N, Takahashi H, Simizu B.
    Cancer Res; 1993 Jul 01; 53(13):3179-85. PubMed ID: 8319227
    [Abstract] [Full Text] [Related]

  • 4. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
    Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM.
    Cancer Res; 1992 Mar 01; 52(5):1364-8. PubMed ID: 1737399
    [Abstract] [Full Text] [Related]

  • 5. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, Siegel SE, Seeger RC.
    Cancer; 2004 Oct 15; 101(8):1873-81. PubMed ID: 15386308
    [Abstract] [Full Text] [Related]

  • 6. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
    Kogner P, Barbany G, Dominici C, Castello MA, Raschellá G, Persson H.
    Cancer Res; 1993 May 01; 53(9):2044-50. PubMed ID: 8481906
    [Abstract] [Full Text] [Related]

  • 7. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM.
    N Engl J Med; 1993 Mar 25; 328(12):847-54. PubMed ID: 8441429
    [Abstract] [Full Text] [Related]

  • 8. Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas.
    Matsunaga T, Takahashi H, Ohnuma N, Tanabe M, Yoshida H, Iwai J, Shirasawa H, Simizu B.
    Cancer Res; 1991 Jun 15; 51(12):3148-52. PubMed ID: 2039993
    [Abstract] [Full Text] [Related]

  • 9. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
    Kogner P, Barbany G, Björk O, Castello MA, Donfrancesco A, Falkmer UG, Hedborg F, Kouvidou H, Persson H, Raschella G.
    Prog Clin Biol Res; 1994 Jun 15; 385():137-45. PubMed ID: 7972205
    [Abstract] [Full Text] [Related]

  • 10. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas.
    Matsunaga T, Shirasawa H, Tanabe M, Ohnuma N, Kawamura K, Etoh T, Takahashi H, Simizu B.
    Int J Cancer; 1994 Sep 15; 58(6):793-8. PubMed ID: 7523310
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
    Fan L, Iyer J, Zhu S, Frick KK, Wada RK, Eskenazi AE, Berg PE, Ikegaki N, Kennett RH, Frantz CN.
    Cancer Res; 2001 Feb 01; 61(3):1073-9. PubMed ID: 11221835
    [Abstract] [Full Text] [Related]

  • 12. Neuronal src and trk a protooncogene expression in neuroblastomas and patient prognosis.
    Matsunaga T, Shirasawa H, Enomoto H, Yoshida H, Iwai J, Tanabe M, Kawamura K, Etoh T, Ohnuma N.
    Int J Cancer; 1998 Jun 19; 79(3):226-31. PubMed ID: 9645342
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction.
    Melegh Z, Bálint I, Tóth E, Csernák E, Szentirmay Z, Nagy K.
    Pediatr Pathol Mol Med; 2003 Jun 19; 22(3):213-22. PubMed ID: 12746172
    [Abstract] [Full Text] [Related]

  • 16. Multifocal neuroblastoma: biologic behavior and surgical aspects.
    Hiyama E, Yokoyama T, Hiyama K, Yamaoka H, Matsuura Y, Nishimura Si, Ueda K.
    Cancer; 2000 Apr 15; 88(8):1955-63. PubMed ID: 10760774
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of multiple drug resistance gene, MDR1, and N-myc oncogene in an Italian population of human neuroblastoma patients.
    Corrias MV, Cornaglia-Ferraris P, Di Martino D, Stenger AM, Lanino E, Boni L, Tonini GP.
    Anticancer Res; 1990 Apr 15; 10(4):897-902. PubMed ID: 1974410
    [Abstract] [Full Text] [Related]

  • 20. Coexpression of the myc gene family members in human neuroblastoma cell lines.
    Hemmi H, Yamada K, Yoon UH, Kato M, Taniguchi F, Tsuchida Y, Shimatake H.
    Biochem Mol Biol Int; 1995 Aug 15; 36(6):1135-41. PubMed ID: 8535284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.